Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors

Clinical trial NCT00088595 · COMPLETED

Trial details

NCT number: NCT00088595
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoid Tumors

Start date: 2004-01-01
Primary completion: 2008-07-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.